Welcome for PCWC BJUI supplement A global perspective from the Prostate Cancer World Congress
Efficacy and safety of abiraterone acetate in asymptomatic or mildly symptomatic chemotherapy-naïve patients with metastatic castrationresistant prostate cancer: a phase III, double-blind, randomized, placebo-controlled study conducted in China, Malaysia, Thailand and Russia
Permanent interstitial low-dose-rate brachytherapy for patients with clinically localized prostate cancer in Singapore
Chidambaram scrotal dressing
PSA and the detection of prostate cancer in a multi-ethnic Asian setting
A prospective study evaluating functional outcome of palliative transurethral resection in locally advanced and metastatic prostate cancer
Prospective evaluation of the utility of %p2PSA and the Prostate Health Index (PHI), in predicting prostate cancer in initial prostate biopsies of Singaporean men, with total PSA between 4.0 and 10 ng/mL
Risk of second primary cancer among prostate cancer patients in Korea: a population-based cohort stud
Should we be investing in the training of laparoscopic radical prostatectomy in Australia? A cost analysis based on the Australian experience of 2,735 cases
Is active surveillance safe for patients with intermediate-risk prostate cancer?
Effect of serum testosterone and percent tumor volume on extraprostatic extension and biochemical recurrence after laparoscopic radical prostatect
Diagnostic utility of noninvasive testing and transrectal ultrasound in prostate carcinoma
Initial results of the intensitymodulated radiation therapy for localized and locally advanced prostate cancer (IMRT)
Correlation and diagnostic performance of PSA level with the diagnosis, aggressiveness and bone metastasis of prostate cancer in clinical practice
The role of androgen deprivation therapy in prostate cancer patients with non-metastatic disease recurrence after local curative treatment: a systematic review
Bowel quality of life after prostate external beam radiation therapy in Victoria
Impact and needs of prostate cancer survivors in a country with low incidence of prostate cancer
Gene expression profile of recurrent prostate cancer
Prostate-specific antigen bounce after intensity-modulated radiation therapy in an Asian population
Prevention and management of complications during roboticassisted laparoscopic radical prostatectomy from comprehensive planning: experience of a single surgeon of 1,000 cases
Predictors of prostate cancer detection at repeat biopsy in patients with previous diagnoses of atypical small acinar proliferation
A cost utility analysis of prostate cancer screening and surveillance in Australia
Severing neurovascular bundle at only one side adversely affects short term continence recovery after radical prostatectomy in high risk prostate cancer patients
Comparison of prostate specific antigen and prostate health index in guiding the decision on transrectal ultrasound-guided prostate biopsy: an indirect cost analysis
TRUS biopsy of the prostate does not result in a higher rate of urosepsis when compared to template biopsy
Abiraterone acetate after docetaxel-based chemotherapy failure in Asian patients with metastatic castration-resistant prostate cancer
Androgen deprivation therapy and the risk of acute myocardial infarction in Chinese men with prostate cancer
Biochemical recurrence rates in active surveillance candidates and the role of improving Gleason grading
Determining three prognostic group using roach formula and other prognostic factors in chinese populations with localized prostate cancer treated with intensitymodulated radiotherapy (IMRT)
The reduction of infection rate using standardize peri-operative and post-operative protocol for ultrasound-guided prostate biopsy: 5 years clinical experience of 583 patients at Changhua Christian Hospital
Rates and predictive factors of Gleason score upgrade in a cohort of Australian men undergoing robotic-assisted radical prostatectomy
Pathologic findings in patients who underwent robot-assisted radical prostatectomy following active surveillance: a prospective study in a single center
Antitumor activity of taxane chemotherapy as first subsequent therapy after abiraterone acetate (AA) in study COU-AA-302 for metastatic castration-resistant prostate cancer (mCRPC)
The Australian laparoscopic non robotic radical prostatectomy experience - analysis of 2,943 cases
Health economic modelling for treatments and services in prostate cancer care: a master model for Australia
Using the clinico-genetic model for predicting lymph node invasion by genome-based biomarkers from exome array among prostate cancer patients
Outcome analysis of transperitoneal versus extraperitoneal robot assisted radical prostatectomy: a singlecentre, single-surgeon experience
Quality of life of patients having transperineal biopsies for the diagnosis of prostate cancer
The PREVAIL trial of enzalutamide (ENZA) in men with chemotherapynaïve, metastatic castrationresistant prostate cancer (mCRPC): subgroup analysis of Asian patients
Magnetic resonance imaging for prostate cancer - a review of comparative studies including template transperineal biopsy and radical prostatectomy specimens
Magnetic resonance imaging for prostate cancer - a comparative study including radical prostatectomy specimens
Long-term (LT) Exposure to lowdose prednisone given with or without abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC) patients
Correlation between clinical and pathological parameters in patients diagnosed with localized prostate cancer who underwent radical prostatectomy: implications on active surveillance as a form of initial management in Filipino patients
Robotic-assisted laparoscopic radical prostatectomy for preoperatively suspicious prostate cancer patients - is a novel indication for robotic surgery?
Patterns of surgical care of prostate cancer in New South Wales: a population-based descriptive study
Lympho-vascular involvement of seminal vesicle invasion in prostatic adenocarcinoma correlates biochemical recurrence free survival in the radical prostatectomy series
A retrospective analysis of South Australian and Victorian clinical registries for prostate cancer
Open versus robotic-assisted radical prostatectomies in the Victorian prostate cancer registry (PCR) - analysis at 2-year follow-up
Using active surveillance in biopsy proven Gleason 3 + 4 prostate cancer
Transrectal USS guided prostate needle biopsy as outpatient under local anaesthesia in regional setting
The utility of multiparametric MRI guided transperineal prostate biopsy in the detection of occult prostatic cancer: a single operator experience
Prostate cancer and melanoma: are there shared risk factors?
Concomitant salvage radical prostatectomy with partial nephrectomy in a patient with radio-resistant prostate cancer with an incidental renal mass: a case report
Prostate health index and %p2PSA predict worse pathological outcomes in radical prostatectomy in Chinese men
Impact of PSMA PET scan on prostate cancer management
Role of pre-treatment factors in response of castrate resistant prostate cancer patients to docetaxel therapy: the indian experience
Do active surveillance patients have an increased risk of TRUS sepsis?
Risk determinants of prostate cancer in the NSW Cancer Lifestyle and Evaluation of Risk Study (CLEAR)
The changing profile of prostate cancer in South Australia
MRI invisible prostate cancer - can we discharge patients with PIRADS score 1 or 2 without a prostate biopsy?
Magnetic resonance imagingultrasound fusion targeted transperineal biopsy: ‘hitting the target or the bulls eye?’ A concordance study with radical prostatectomy specimens
Delays in prostate cancer treatment following diagnosis
The short-term efficacy and safety of post chemotherapy abiraterone acetate with prednisone in metastatic castration-resistant prostate cancer patients in VGHTC
Risk of suicide after a prostate cancer diagnosis: a populationwide study in New South Wales (NSW) Australia
Satisfaction with care in men with prostate cancer
Ten-year quality of life and psychological outcomes of men managed entirely with active surveillance: The NSW Prostate Cancer Care and Outcomes Study
Men presenting with prostate specific antigen (PSA) levels over 100 ng/mL at the time of diagnosis
Does patient obesity influence prostate motion during external beam radiation therapy?
Malignant priaprism - a rare manifestation of prostate cancer
Oncological and functional outcomes of laparoscopic radical prostatectomies (LRP) - findings in the Victorian Prostate Cancer Registry (PCR)
Prostate cancer detection rate in Indonesian men
Correlation between multiparametric MRI findings and radical prostatectomy specimens
Clinical significance of focal atrophy in benign prostatic hyperplasia patients
Comparison of non-index tumours found in radical prostatectomy specimens and their detection by multiparametric MRI: what are the implications for focal therapy?
ASPIRE-PCa: initial findings from a prospective, global observational study of men with late-stage prostate cancer
Neurovascular bundle stimulation results in rhabdosphincter contraction in a proportion of men undergoing radical prostatectomy
Evaluation of detection rate of 68Ga-PSMA-ligand PET/CT for biochemical recurrence after radical prostatectomy
Re-do prostatectomy after subtotal robotic assisted laparoscopic radical prostatectomy
Preliminary experience on the use of Tachosil® in robot-assisted laparoscopic radical prostatectomy (RaLRP)
What do urologists think patients need to know when starting on androgen deprivation therapy? The perspective from canada versus countries with lower gross domestic product
Prospective comparison of the detection rate of 18F-Fluoromethylcholine and 68Ga-PSMA-HBED PET/CT in men with prostate cancer with rising PSA post curative treatment, being considered for targeted therapy
Prospective study of pre-biopsy multiparametric magnetic resonance imaging (mpMRI) compared to transperineal template mapping biopsy (TTMB) for detection of clinically significant prostate cancer: is it accurate enough to guide selection of men for biopsy?
Cardamonin inhibits signal transducer and activator of transcription 3 activation by directly binding SH2 to its domain in prostate cancer cells
Depletion of L1CAM by siRNA inhibits prostatic cancer cell invasion in vitro
Comparison of patient-reported quality-of-life and complications in men with prostate cancer, between two modes of administration
A descriptive analysis of diagnostic and treatment characteristics of men with prostate cancer from a regional area with high mortality rates in Victoria, Australia
Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer chemo-/radio-resistance in cell lines in vitro and in animal models in vivo
Reactive stroma componentCOL6A1 is upregulated in castration-resistant prostate cancer and promotes tumor growth
Heberprovac, a therapeutic GnRH based vaccine to treat advanced prostate cancer
Inhibition of ASCT2-mediated glutamine uptake blocks prostate cancer growth
Multimodality imaging of a novel spontaneous prostate cancer liver metastasis model
The mutational landscape of the mitochondrial genome in prostate cancer
Enrichment and propagation of circulating tumour cells in men with hormone naïve metastatic prostate cancer
Investigating the role of a potential angiogenic target, YKL40, for the treatment of metastatic prostate cancer
Combination of LBH589 and radiotherapy overcomes radioresistance in radioresistant prostate cancer cells in vitro and animal models in vivo
The ghrelin receptor antisense long non-coding RNA, GHSROS, in prostate cancer growth and survival
Multimodal hyperbranched polymers targeting prostate specific membrane antigen (PSMA) for imaging of prostate cancer
PI3K/Akt signalling regulates leucine transport in prostate cancer
Elucidating the role of ZEB1 in metastatic castration resistant prostate cancer
Visualization of next generation sequencing data
Impeding the adaptive response of prostate cancer to androgen targeted therapies with relaxin receptor antagonist
Characterisation of novel primary tumour derived epithelial prostate cancer cell lines
A multiple nucleotide length polymorphism (MNLP) mediates androgen regulation of IRX4 in prostate cancer
Moduiation of protease expression in prostate cancer cells after androgen deprivation
Extracellular vesicles mediate paracrine signalling in androgen deprived prostate cancer
Polysaccharopeptide enhanced the anti-cancer effect of gammatocotrienol through activation of AMPK
Kallikrein-related peptidase 4 induces tumour microenvironment alterations that support tumour growth
A 3D in vitro model reflecting the androgen deprivation state in prostate cancer bone metastasis
MSH2 translocations are associated with clinically aggressive prostate cancer
Combination of inhibitors of Hsp90 chaperone activity and inhibitors of Hsp induction for better targeting human prostate cancer
The Hsp90 inhibitor, NVP-AUY922, produces anti-tumour activity through inhibition of fibronectin polymerization resulting in cytoskeletal reorganization
High risk prostate cancer is associated with distinct transcriptional and lipid profiles in adipose tissue
Investigating the role of neuroendocrine transdifferentiation in the progression to castration resistant prostate cancer
Targeting neuropilin-1 to inhibit prostate cancer invasion and metastasis
The mesenchymal-to-epithelial reverting transition is enriched in metastatic castration resistant prostate cancer and correlates with poor survival
The essential role of ARF in prostate cancer microenvironment
Resistance to abiraterone based castration is not predicted by ARv7 status in high-risk prostate cancer
RNA-Seq of localized prostate cancer treated with “supercastration” therapy
Mitochondrial genomic variation and prostate cancer in South African men
A tale of tails - novel approach to immunotherapy of prostate cancer
Australian prostate cancer bioresource, 2015
Insulin increases apoptotic resistance in prostate cancer cells, but are sensitised by metformin
Leptin receptor antagonist, Allo-Aca, prevents migration, invasion and modifies lipogenesis pathways in prostate cells
SUMOylation regulates stability and function of the receptor tyrosine kinase EphB4
Carica papaya leaf juice extracts have selective anti-proliferative responses in prostatic disease
Evaluation of prostate oedema following permanent fiducial marker insertion in prostate cancer patients treated at the Townsville Cancer Centre (TCC)
Investigation of deregulated lipid metabolism in advanced prostate cancer
YB-1, a key regulator of androgen receptor signaling
Tracking the origins and drivers of metastasis in prostate cancer
Multianalyte assay for prostate cancer
Determining the evolutionary origin of lymph node metastases in prostate cancer
Factors affecting chromosomal translocations in prostate cancer
A specific expression signature accurately predicts high grade prostate tumours in fat but not from adjacent benign tissues
Targeting adaptive nutrient metabolism pathways as a therapy for prostate cancer
Aggressive prostate cancer presentation within an African setting - are bacterial pathogens contributing to exasperated disease course?
Rethinking stromal cells contribution in the drug screening approach of prostate cancer
Minimally invasive surgery employing antagonistic, inflatable robot: evaluation of positioning accuracy and motion dynamics
Patient-derived prostate cancer cells for piloting of drug sensitivity and resistance testing
Genome Mapping - a new strategy to detect complex prostate cancer structural genomic rearrangements
An Irish collaborative nursing approach to quality patient information: a national audit on patient written information post transrectal ultrasound guided biopsy
Remote monitoring of advanced prostate cancer patients after androgen deprivation therapy using mobile health technology: opportunities for novel care models
Couple therapy for men and their partners following prostate cancer diagnosis
Evaluation of the Prostate Cancer Clinical Nurse Co-ordinator (PC-CNC) role in Australia
ASTROID (Active Surveillance and other Treatment Options for Prostate Cancer): a decision aid
Supportive care needs of prostate cancer patients living in urban and rural/regional areas in Australia
Pre-surgical exercise programming to improve outcomes for men undergoing prostatectomy
Instructions to ‘stop the urine flow’ prior to radical prostate surgery produces quantifiable bladder neck elevation when assessed clinically with transperineal ultrasound
Doing qualitative research: an introduction
The missing piece of the men's health puzzle: developing Australian's first prostate cancer and men's health centre
Does partnership status affect the quality of life of men having robotic-assisted radical prostatectomy (RARP) for localised prostate cancer?
‘Lets talk about sex’: a prospective audit of a Nurse Practitioner-led sexual health and erectile dysfunction (SHED) Clinic
Surgical nursing is not just fast paced it can be supportive as well: The introduction of the Prostate Cancer Specialist Nurse at Greenslopes Private Hospital
Proving a concept-delivering long term care to men living with prostate cancer
Physical activity levels in men with bone metastatic prostate cancer and associations with physical and mental health outcomes
Diverse function of the pelvic floor muscles in men: investigation of the speech-related activation of the striated urethral sphincter and puborectalis muscles
Interpretation of transperineal ultrasound imaging of pelvic floor muscle contraction in men
Maintaining bone health in men with prostate cancer
Musculoskeletal comparison of patients with localised versus metastatic prostate cancer
PROSTMATE: web-based technology to support men with prostate cancer
Clinical usefulness of the supportive care needs survey for men with advanced prostate cancer
Multidisciplinary team meetings, do they make a difference? A systematic review of the impact of multidisciplinary team meetings on patient assessment, management and outcomes